Tender detail
Medicinal products containing bimekizumab (ATC L04AC21)
Summary
The procurement concerns non-exclusive discount agreements under Section 130a(8) of the German Social Code Book V for finished medicinal products containing the active ingredient bimekizumab (ATC L04AC21). The agreements are offered through an open-house model with uniform contract terms and a uniform access procedure.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.